Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry
Date
1999
Authors
Loubser O.
Marais A.D.
Kotze M.J.
Godenir N.
Thiart R.
Scholtz C.L.
De Villiers J.N.P.
Hillermann R.
Firth J.C.
Weich H.F.H.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The South African population harbors genes that are derived from varying degrees of admixture between indigenous groups and immigrants from Europe and the East. This study represents the first direct mutation-based attempt to determine the impact of admixture from other gene pools on the familial hypercholesterolemia (FH) phenotype in the recently founded Coloured population of South Africa, a people of mixed ancestry. A cohort of 236 apparently unrelated patients with clinical features of FH was screened for a common mutation causing familial defective apolipoprotein B-100 (FDB) and seven low-density lipoprotein receptor (LDLR) gene defects known to be relatively common in South Africans with FH. Six founder-type 'South African mutations' were responsible for FH in ~ 20% of the study population, while only 1 patient tested positive for the familial defective apolipoprotein B-100 mutation R3500Q. The detection of multiple founder-type LDLR gene mutations originating from European, Indian and Jewish populations provides direct genetic evidence that Caucasoid admixture contributes significantly to the apparently high prevalence of FH in South African patients of mixed ancestry. This study contributes to our knowledge of the biological history of this unique population and illustrates the potential consequences of recent admixture in populations with different disease risks.
Description
Keywords
apolipoprotein b100, low density lipoprotein receptor, article, clinical feature, controlled study, DNA determination, ethnic group, familial hypercholesterolemia, founder effect, gene mutation, human, human cell, major clinical study, phenotype, population genetics, priority journal, receptor gene, South Africa, Founder Effect, Haplotypes, Humans, Hyperlipoproteinemia Type II, Mutation, Phenotype, Prevalence, Receptors, LDL, South Africa
Citation
Clinical Genetics
55
5
55
5